US4013652A
(en)
*
|
1972-06-19 |
1977-03-22 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzoxazine
|
US4183936A
(en)
*
|
1972-06-19 |
1980-01-15 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzheterocycles
|
US4115577A
(en)
*
|
1972-06-19 |
1978-09-19 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzheterocycles
|
DE2922756A1
(de)
*
|
1978-06-05 |
1979-12-06 |
Sankyo Co |
Benzothiazocine, benzothiazocinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzung
|
US4219550A
(en)
*
|
1978-11-09 |
1980-08-26 |
E. I. Du Pont De Nemours And Company |
Cis- and trans- octahydropyridopyrrolobenzheterocycles
|
EP0357417A1
(en)
*
|
1988-09-01 |
1990-03-07 |
Glaxo Group Limited |
Lactam derivatives
|
US5223625A
(en)
*
|
1988-12-22 |
1993-06-29 |
Duphar International Research B.V. |
Annelated indolo [3,2,-C]lactams
|
EP0380155A1
(en)
*
|
1989-01-19 |
1990-08-01 |
Duphar International Research B.V |
8,9-Annelated-1,2,3,4-tetrahydro-beta-carboline derivatives
|
DE60014370T2
(de)
|
1999-06-15 |
2006-02-09 |
Bristol-Myers Squibb Pharma Co., Wilmington |
Substituierte heterocyclylkondensierte gamma carboline
|
US6713471B1
(en)
*
|
1999-06-15 |
2004-03-30 |
Bristol-Myers Squibb Pharma Company |
Substituted heterocycle fused gamma-carbolines
|
US7071186B2
(en)
*
|
1999-06-15 |
2006-07-04 |
Bristol-Myers Squibb Pharma Co. |
Substituted heterocycle fused gamma-carbolines
|
EP1343791A2
(en)
*
|
2000-12-20 |
2003-09-17 |
Bristol-Myers Squibb Company |
Substituted tetracyclic pyridoindoles as serotonin agonists and antagonists
|
US6849619B2
(en)
*
|
2000-12-20 |
2005-02-01 |
Bristol-Myers Squibb Company |
Substituted pyridoindoles as serotonin agonists and antagonists
|
AU2002248216B2
(en)
|
2000-12-20 |
2007-03-01 |
Bristol-Myers Squibb Pharma Company |
Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists
|
IL156261A0
(en)
|
2000-12-20 |
2004-01-04 |
Bristol Myers Squibb Co |
Pyrroloquinoline and pyridoquinoline derivatives and pharmaceutical compositions containing the same
|
BR0212676A
(pt)
*
|
2001-09-21 |
2006-05-23 |
Upjohn Co |
compostos terapêuticos ligantes de 5-ht, composições farmacêuticas compreendendo tais compostos e seus usos
|
ATE509929T1
(de)
*
|
2002-12-19 |
2011-06-15 |
Bristol Myers Squibb Co |
Substituierte tricyclische gamma-carbolineals serotonin-rezeptor-agonisten und antagonisten
|
KR102107954B1
(ko)
|
2007-03-12 |
2020-05-07 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
치환된 헤테로환 융합 감마-카르볼린 합성
|
US8575186B2
(en)
|
2009-10-05 |
2013-11-05 |
Albany Molecular Research, Inc. |
Epiminocycloalkyl[b] indole derivatives as serotonin sub-type 6 (5-HT6) modulators and uses thereof
|
EP2668191A4
(en)
|
2011-01-19 |
2014-08-20 |
Albany Molecular Res Inc |
BENZOFURO- [3,2-C-] PYRIDINES AND RELATED ANALOGS AS SEROTONIN-SUBTYPE-6 (5-HT6) MODULATORS FOR THE TREATMENT OF ADIPOSITAS, METABOLISM SYNDROME, COGNITION AND SCHIZOPHRENIA
|
EP2836213B1
(en)
|
2012-04-14 |
2018-07-04 |
Intra-Cellular Therapies, Inc. |
Fused gamma carbolines
|
PL2968320T3
(pl)
|
2013-03-15 |
2021-05-17 |
Intra-Cellular Therapies, Inc. |
Związki organiczne
|
KR20230023817A
(ko)
|
2013-12-03 |
2023-02-17 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
신규한 방법
|
CN106456638A
(zh)
|
2014-04-04 |
2017-02-22 |
细胞内治疗公司 |
有机化合物
|
RU2020123764A
(ru)
|
2014-04-04 |
2020-08-05 |
Интра-Селлулар Терапиз, Инк. |
Органические соединения
|
PL3407888T3
(pl)
|
2016-01-26 |
2021-08-30 |
Intra-Cellular Therapies, Inc. |
Związki pirydopirolochinoksaliny, ich kompozycje i zastosowania
|
EP3888656A1
(en)
|
2016-03-25 |
2021-10-06 |
Intra-Cellular Therapies, Inc. |
Deuterated heterocyclic gamma-carboline compounds and their use in the treatment or prophylaxis of a central nervous system disorder
|
JP2019513143A
(ja)
|
2016-03-28 |
2019-05-23 |
イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. |
新規塩類および結晶
|
WO2017172811A1
(en)
|
2016-03-28 |
2017-10-05 |
Intra-Cellular Therapies, Inc. |
Novel co-crystals
|
EP3436083A4
(en)
|
2016-03-28 |
2019-11-27 |
Intra-Cellular Therapies, Inc. |
NEW COMPOSITIONS AND METHODS
|
US11331316B2
(en)
|
2016-10-12 |
2022-05-17 |
Intra-Cellular Therapies, Inc. |
Amorphous solid dispersions
|
JP6987868B2
(ja)
|
2016-12-29 |
2022-01-05 |
イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. |
有機化合物
|
WO2018126140A1
(en)
|
2016-12-29 |
2018-07-05 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
MX2021013640A
(es)
|
2017-03-24 |
2022-08-31 |
Intra Cellular Therapies Inc |
Composiciones novedosas y metodos.
|
CA3071137A1
(en)
|
2017-07-26 |
2019-01-31 |
Intra-Cellular Therapies, Inc. |
Prodrugs of substituted heterocycle fused gamma-carbolines
|
IL272249B2
(en)
|
2017-07-26 |
2023-11-01 |
Intra Cellular Therapies Inc |
organic compounds
|
MX2020013335A
(es)
|
2018-06-08 |
2021-05-27 |
Intra Cellular Therapies Inc |
Metodos novedosos.
|
CN110831941A
(zh)
|
2018-06-11 |
2020-02-21 |
细胞内治疗公司 |
取代的杂环稠合的γ-咔啉类化合物合成
|
CA3108553A1
(en)
|
2018-08-31 |
2020-03-05 |
Intra-Cellular Therapies, Inc. |
Novel methods
|
JP7457000B2
(ja)
|
2018-08-31 |
2024-03-27 |
イントラ-セルラー・セラピーズ・インコーポレイテッド |
新規方法
|